| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |